| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/22/2010 | CA2749051A1 Methods for identifying patients who will respond well to cancer treatment |
| 07/21/2010 | EP2208498A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency |
| 07/21/2010 | EP2207424A1 Compositions and methods for treating purpura |
| 07/21/2010 | EP2051703B1 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 07/21/2010 | EP1732604B1 Methods of treating hiv infection |
| 07/21/2010 | EP1539202B1 Compositions based on plant extracts for the treatment of cancer |
| 07/21/2010 | EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment |
| 07/21/2010 | EP1444516B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 07/21/2010 | EP1411900B1 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 07/21/2010 | EP1372529B1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | EP1181034B1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1917903B New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 07/21/2010 | CN101784551A bicycloaniline derivative |
| 07/21/2010 | CN101784287A Aqueous composition |
| 07/21/2010 | CN101784286A Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor |
| 07/21/2010 | CN101784285A Composition for ophthalmic disease associated with hypoxia or ischemia |
| 07/21/2010 | CN101784195A New compositions and methods for cell killing |
| 07/21/2010 | CN101780281A Application of N-arginine chitosan as percutaneous sorbefacient |
| 07/21/2010 | CN101780279A Application of Toll-link receptor-3 agonist to preparation of medicines for promoting wound healing |
| 07/21/2010 | CN101780095A Antidiabetic formulation and method |
| 07/21/2010 | CN101780092A Compounds and methods for delivery of prostacyclin analogs |
| 07/21/2010 | CN101780080A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 07/21/2010 | CN101352426B Osmotic pump controlled release preparation composition and preparation thereof |
| 07/21/2010 | CN101229376B Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/21/2010 | CN101069745B Medicine composition for treating 2-type diabetes |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759472 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759346 [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 07/20/2010 | US7759332 liver, lung, skin, breast, brain glioma, colon and rectum, stomach, head and neck, leukemia, malignant lymphoma, sarcoma, malignant melanoma, myeloma, and metastasis cancers |
| 07/20/2010 | US7759322 Method of treating dry eye disease with purinergic receptor agonists |
| 07/20/2010 | US7759106 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759078 Diagnosis and treatment of cancer |
| 07/20/2010 | US7759068 Eukaryotic cells are treated with a polynucleotide which encodes a polypeptide which inhibits the expression or the function of proteins synthesized or secreted by tumors, and thus inhibits the increase in tissue volume or the metastasis of the tumors; for prostatic tissue |
| 07/20/2010 | US7758898 Copper lowering treatment of inflammatory and fibrotic diseases |
| 07/20/2010 | US7758887 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 07/20/2010 | US7758876 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/20/2010 | US7758853 A protein obtainable from mouse liver, able to produce interferon- gamma by immunocompetent cells; producing antitumor agent |
| 07/20/2010 | US7758852 OX40R binding agents |
| 07/20/2010 | CA2540447C Apparatus and method for administering a therapeutic agent into tissue |
| 07/20/2010 | CA2455680C Ophthalmic depot formulations for periocular or subconjunctival administration |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2406077C Formulation for the prevention of cardiovascular disease |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/20/2010 | CA2288983C Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 07/20/2010 | CA2282906C Stable complexes of poorly soluble compounds |
| 07/20/2010 | CA2271249C Macromolecular neuraminidase-binding compounds |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/15/2010 | WO2010080757A2 Combinations with an alpha-4beta-2 nicotinic agonist |
| 07/15/2010 | WO2010080170A1 Combination therapies for neoplastic disorders |
| 07/15/2010 | WO2010079819A1 Pharmaceutical composition for treating obesity or diabetes |
| 07/15/2010 | WO2010079811A1 Gene sensitive to diseases associated with intervertebral disc degeneration, and use thereof |
| 07/15/2010 | WO2010079305A1 Anti-snoring composition containing a thermogelling polymer |
| 07/15/2010 | WO2010079197A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor |
| 07/15/2010 | WO2010078916A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | WO2010047999A3 Method for treating pulmonary arterial hypertension |
| 07/15/2010 | WO2009103727A3 Combination of an iron chelator and an immunosuppressant and use thereof |
| 07/15/2010 | WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 07/15/2010 | US20100179200 2-oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100178354 Remedy |
| 07/15/2010 | US20100178304 Method for silk fibroin gelation using sonication |
| 07/15/2010 | US20100178287 Use of coagulation proteins to lyse clots |
| 07/15/2010 | US20100176340 Buffered compositions for dialysis |
| 07/15/2010 | DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen |
| 07/15/2010 | DE102009004959A1 Use of at least one transaminase inhibitor for producing an agent for the prophylaxis and treatment of pityriasis versicolor |
| 07/15/2010 | CA2749261A1 Combination therapies for neoplastic disorders |
| 07/15/2010 | CA2747154A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | CA2745039A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor |
| 07/14/2010 | EP2206727A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 07/14/2010 | EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor |
| 07/14/2010 | EP2206709A2 Thiophene derivatives as antiviral agents for flavivirus infection |
| 07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
| 07/14/2010 | EP2206533A2 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene hydrazino -2'-hydroxy- 1,1'-biphenyl -3-carboxylic acid bis-(monoethanolamine) |
| 07/14/2010 | EP2206518A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor |
| 07/14/2010 | EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies |
| 07/14/2010 | EP2206504A1 Stable bicarbonate ion-containing drug solution |
| 07/14/2010 | EP2205248A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 07/14/2010 | EP2205077A1 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| 07/14/2010 | EP2205076A1 Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr ýerbb1¨and her-2 ýerbb2¨ |
| 07/14/2010 | EP1585524B1 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 07/14/2010 | EP1514116B9 Oxaliplatin anti-resistance method |
| 07/14/2010 | EP1490030B2 Nanoparticulate compositions of angiogenesis inhibitors |
| 07/14/2010 | EP1261357B1 Isolation and transplantation of retinal stem cells |
| 07/14/2010 | EP1222226B1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/14/2010 | CN1882508B Process for preparing water soluble diterpenes and their applications |
| 07/14/2010 | CN101778934A Cd34 stem cell-related methods and compositions |
| 07/14/2010 | CN101778641A Preventive/remedy for cancer |
| 07/14/2010 | CN101778625A tableted compositions containing atazanavir |
| 07/14/2010 | CN101778624A tableted compositions containing atazanavir |
| 07/14/2010 | CN101778608A Improvements in and relating to mammalian reproduction |
| 07/14/2010 | CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/14/2010 | CN101773485A Sustained-release preparation using S-metoprolol and dihydropyridine calcium channel blocker as active components and preparation method and use thereof |
| 07/14/2010 | CN101773483A Preparation method of water-insoluble drug microcapsule |